NCT07045909
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07045909
Title Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST) (GEM-AnitoFIRST)
Acronym GEM-AnitoFIRST
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PETHEMA Foundation
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Germans Trias i Pujol (ICO BADALONA) RECRUITING Badalona Spain Details
H. Clinic de Barcelona RECRUITING Barcelona Spain Details
H. 12 de Octubre RECRUITING Madrid Spain Details
H. Ramón y Cajal RECRUITING Madrid Spain Details
Clinica Universidad de Navarra RECRUITING Pamplona Spain Details
Hospital Clinico Universitario Salamanca RECRUITING Salamanca 37007 Spain Details
H. Marqués de Valdecilla RECRUITING Santander Spain Details
C H Santiago de Compostela RECRUITING Santiago de Compostela Spain Details
Complejo Hosp. Regional Virgen del Rocío RECRUITING Seville 41013 Spain Details
Hospital Universitario y Politécnico La Fe de Valencia RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field